MPS II Immunophenotyping
study id #: NCT04976231
condition: MPS II, Mucopolysaccharidosis II, Hunter Syndrome
status: Not yet recruiting
purpose:The purpose of this study is to investigate how participant’s body’s immune system responds to idursulfase, an enzyme replacement therapy (ERT) and find out which types of immune cells are involved in causing untoward responses to the ERT so that the investigators can relate the level of immune response to the treatment.
results: https://clinicaltrials.gov/ct2/show/results/NCT04976231
last updated: February 26, 2022
-
Facial and Cephalometric Features of Individuals With Mucopolysaccharidosis: A Cross-Sectional StudyThe aim was to assess craniofacial featu...
-
X-Linked Recessive Inheritance Pattern in MPS II (Hunter Syndrome)https://www.onempsvoice.com/wp-content/u...
-
Disease Manifestations in Mucopolysaccharidoses and Their Impact on Anaesthesia-Related Complications-A Retrospectiv...Patients with mucopolysaccharidoses (MPS...
-
Open-Label Phase 1/2 Study of Vestronidase Alfa for Mucopolysaccharidosis VIIVestronidase alfa is an enzyme replaceme...
-
Medical Travel Assistance Program (MTAP)Program provides financial assistance of...
-
Molecular Analysis of Vietnamese Patients With Mucopolysaccharidosis Type IMucopolysaccharidosis type I (MPS I) is ...
-
Mucopolysaccharidosis (MPS)https://slideplayer.com/slide/17257432/...